ORKA insider buying – Oruka Therapeutics, Inc.
1 insider purchases since 2016 worth $1.4M by 1 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2025-02-27.
Mid company Public float $372M (latest 10-K, SEC).
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| VHCP Management III, LLC 10% Owner | $1.4M 1× · 122,882 sh | 2025-02-10 2025-02-10 | – | 4,035,713 shares as of 2025-02-27 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 0 | – | – | 35 | $336.2M |
| 2025 | 1 | $1.4M | 1 | 1 | $214,289 |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2025-02-27 | VHCP Management III, LLC | 10% Owner | 122,882 | $11.45 | $1.4M | +3.1% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-11-13 | Agarwal Arjun | Senior Vice President, Finance | -10,000 | $104.97 | $1.0M | Pre-planned (10b5-1) | SEC |
| 2026-11-13 | BALL KRISTINE M | Director | -18,000 | $104.93 | $1.9M | Pre-planned (10b5-1) | SEC |
| 2026-09-21 | Quinlan Paul T | Officer | 10,000 | $93.64 | $936,425 | Pre-planned (10b5-1) | SEC |
| 2026-09-21 | Agarwal Arjun | CEO | 533 | $95.75 | $51,035 | Pre-planned (10b5-1) | SEC |
| 2026-09-15 | Sandler Laura Lee | Officer | 906 | $95.71 | $86,713 | Sale | SEC |
| 2026-09-15 | Quinlan Paul T | Officer | 1,039 | $95.71 | $99,443 | Sale | SEC |
| 2026-09-15 | Klein Lawrence Otto | CEO | 2,452 | $95.71 | $234,681 | Sale | SEC |
| 2026-09-15 | Goncalves Joana | Officer | 7,947 | $92.38 | $734,161 | Pre-planned (10b5-1) | SEC |
| 2026-09-15 | Agarwal Arjun | CEO | 10,019 | $92.42 | $926,003 | Pre-planned (10b5-1) | SEC |
| 2026-09-01 | Sandler Laura Lee | Officer | 5,000 | $91.82 | $459,090 | Pre-planned (10b5-1) | SEC |
| 2026-09-01 | Klein Lawrence Otto | CEO | 75,000 | $91.84 | $6.9M | Pre-planned (10b5-1) | SEC |
| 2026-08-17 | Goncalves Joana | Officer | 7,000 | $111.84 | $782,863 | Pre-planned (10b5-1) | SEC |
| 2026-08-14 | Quinlan Paul T | Officer | 52,000 | $108.49 | $5.6M | Pre-planned (10b5-1) | SEC |
| 2026-08-14 | Agarwal Arjun | CEO | 10,000 | $106.66 | $1.1M | Pre-planned (10b5-1) | SEC |
| 2026-07-15 | Goncalves Joana | Officer | 7,000 | $86.28 | $603,959 | Pre-planned (10b5-1) | SEC |
Showing the latest 15 of 36 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free